TXA administered intravenously, by injection reduces blood loss after knee replacement
Friday, May 20, 2016 - 14:00
in Health & Medicine
Administering tranexamic acid (TXA) both intravenously (IV) and injected at the surgical site (intra-articular administration, or IA) reduced blood loss by 37 percent, compared to IV alone, following total knee replacement (TKR).